title: UISESS scale for staging and classifying clinical-epidemiological risk in type 2 diabetes mellitus and for establishing multidisciplinary preventive actions.
abstract: OBJECTIVE
  The goal of this study is the creation and use of a five-stage scale for the description of the health status of a type 2 diabetes mellitus patient population, as individuals and as a set. The scale, named UISESS, ranges from the pre-pathological to the sequelae stage, and can help orient multidisciplinary prevention actions. SETTING AND SAMPLING: A sample of nondiabetics (n = 404), together with a census of all type 2 diabetic patients (n = 2,702) over 30 years of age, were obtained from a family medicine clinic of the Mexican Federal Social Security System (IMSS) in Guadalajara, Mexico.
  
  
  METHODS
  A descriptive study in which the Natural History of the Disease and an epidemiological focus on risk were used to create the UISESS scale. Case histories of a total of 3,106 persons from a family practice clinic were used. The data was classified in five stages and three risk control levels were used for analysis.
  
  
  RESULTS
  In the type 2 diabetic group, the average age was 57.6 years; 58% were women. In the nondiabetic group, the average age was 55.38 years; 63% were women. The UISESS scale was applied. A large majority (86%) of the studied type 2 diabetic patients were classified within unfavorable stages for controlling their illness, and 65% of the 3,106 people were at high or very high risk of increasing deterioration of their health status.
  
  
  CONCLUSIONS
  The UISESS scale appears to be a useful tool to detect the distribution, evolution and control of type 2 diabetes in a population attended at the outpatient clinic of a family medicine unit, according to the Natural History of the Disease.
authors.affiliation: Unidad de Investigación Social, Epidemiológica y de Servicios de Salud (UISESS), 12 de Diciembre 616 Colonia Chapalita, C.P. 45040 Zapopan, Jalisco, Mexico. javier_91046@yahoo.com
authors.forename: Javier E
authors.initials: JE
authors.lastname: García de Alba
authors.forename: Ana L
authors.initials: AL
authors.lastname: Salcedo Rocha
authors.forename: Cecilia
authors.initials: C
authors.lastname: Colunga Rodríguez
authors.forename: Juan Antonio
authors.initials: JA
authors.lastname: González Barrera
authors.forename: Evangelina
authors.initials: E
authors.lastname: Herrera Solís
authors.forename: María Eugenia
authors.initials: ME
authors.lastname: Milke Najar
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000554:Ambulatory Care Facilities; D001786:Blood Glucose / Q000032:analysis; D016022:Case-Control Studies; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000145:classification* / Q000453:epidemiology / Q000517:prevention & control*; D005194:Family Practice; D005260:Female; D006801:Humans; D008297:Male; D008800:Mexico; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods*; D012016:Reference Values; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012737:Sex Factors
chemical_list: D001786:Blood Glucose